NSD1 and head and neck squamous cell carcinoma: Indeed, increased sensitivity to olaparib was observed in HNSCC cases with concurrent reduction in H3K36 methylation (e.g., due to NSD1 histone methyltransferase mutation) and increase in H3K27 trimethylation.